ALDX Operating Cash Flow Growth
Aldeyra Therapeutics Inc · Operating Cash Flow Growth
ALDX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported46.34%period ending
ALDX TTM Cash from Operations YoY % (-197.84% → 46.34%)
Year-over-year change
High-resolution chart · PNG
ALDX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 46.34% | |
| 43.1449% | |
| 22.8265% | |
| -30.6856% | |
| -33.5766% | |
| -48.1308% | |
| -42.4803% | |
| 27.073% | |
| 34.0841% | |
| 42.0104% | |
| 46.4554% | |
| 26.1934% | |
| 11.8019% | |
| -26.814% | |
| -33.0889% | |
| -45.0137% | |
| -42.4403% | |
| -17.8397% | |
| -13.5022% | |
| 2.7404% | |
| 12.6681% | |
| 25.3742% | |
| 16.652% | |
| 3.1719% | |
| -3.3588% | |
| -38.1574% | |
| -50.6649% | |
| -55.0725% | |
| -71.7899% | |
| -50.2114% | |
| -55.3209% | |
| -48.5468% | |
| -41.466% | |
| -54.7877% | |
| -26.9044% | |
| -27.3721% | |
| -24.3463% | |
| -24.3007% | |
| -62.6709% | |
| -79.2094% | |
| -117.1453% | |
| -115.0706% | |
| -94.9699% | |
| -110.4762% | |
| -103.6076% | |
| -124.713% | |
| -179.8542% | |
| -197.844% |